Analyze Diet

European journal of haematology.

Periodical
Hematology
Publisher:
Munksgaard,. Oxford : Blackwell (2005)
Frequency: Ten no. a year
Country: England
Language: English
Start Year:1987 -
ISSN:
0902-4441 (Print)
1600-0609 (Electronic)
0902-4441 (Linking)
Impact Factor
3.1
2022
NLM ID:8703985
(DNLM):SR0059536(s)
(OCoLC):15468015
Coden:EJHAEC
LCCN:sn 87026192
Classification:W1 EU72DFC
Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
European journal of haematology    November 12, 2009   Volume 84, Issue 2 154-159 doi: 10.1111/j.1600-0609.2009.01378.x
Chang MH, Kim KH, Kim HS, Jun HJ, Kim DH, Jang JH, Kim K, Jung CW.Immunosuppressive therapy (IST) with antithymocyte globulin (ATG) plus cyclosporine (CSA) is standard therapy in patients with severe aplastic anemia (SAA) who do not have an available HLA-matched sibling donor. Methods: The current study aimed to determine the predictive factors for response to IST in patients with SAA and to identify prognostic factors following IST. A total of 62 patients diagnosed with SAA who received IST with either rabbit ATG (n = 33) or horse ATG (n = 29) plus CSA between October 1994 and December 2007 were included. Results: With a median follow-up duration of 60.5 mo...